<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Another clinical trial was performed to evaluate the levels of adipokine in 76 overweight children and adolescents with insulin resistance, not on diet, who took 900 mg of n-3 LCPUFA supplement or placebo for one month. After treatment, insulin and HOMA-IR were significantly decreased in the intervention group, which showed also lower values of serum adiponectin, leptin, and TNF alfa after treatment. Despite no differences at baseline, only the n-3-FAs group had decreased fasting insulin and HOMA-IR. Interaction between supplementation and weight loss was found to be significant [
 <xref rid="B49-ijms-20-02118" ref-type="bibr" class="xref">49</xref>].
</p>
